Posted by JohnBoy2000 on March 11, 2018, at 15:33:19
In reply to Clinical profile of Maprotiline - Vs Strattera??, posted by JohnBoy2000 on March 11, 2018, at 15:15:20
Also - unbearable cardiac side effects from Lofepramine.
I don't get that on any other NA drugs.
Though Lofepramine is reputed to be the least severe cardiac drugs from the tricyclic class...?
Supposedly doesn't have mACh seid effects - but the cause of cardiac issues in my case - what else could it have come from.
That being said - Maprotiline supposedly doesn't have mACh binding - but similar effect profile - via "pseudo" mACh effects due to high NA activation.
Something like that?
poster:JohnBoy2000
thread:1097284
URL: http://www.dr-bob.org/babble/20180212/msgs/1097285.html